Necrotizing cutaneous infection caused by Curvularia brachyspora in an immunocompetent host. | Canada Hyperbarics Skip to main content
Clinical Study The Australasian journal of dermatology 1997

Necrotizing cutaneous infection caused by Curvularia brachyspora in an immunocompetent host.

Torda AJ, Jones PD — The Australasian journal of dermatology, 1997

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented a case report of a necrotizing cutaneous infection caused by Curvularia brachyspora in an immunocompetent host.

What They Found

They found that a 58-year-old man developed necrotizing cellulitis on both thighs after cryotherapy, which did not respond to antibacterial therapy. The patient began to respond to empirical intravenous amphotericin B even before the fungal pathogen, Curvularia brachyspora, was identified.

Canadian Relevance

This study has no direct Canadian connection as it was conducted in Australia.

Study Limitations

As a single case report, the findings of this study have limited generalizability to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Infection
Source Pubmed
PubMed ID 9159965
Year Published 1997
Journal The Australasian journal of dermatology
MeSH Terms Cellulitis; Dermatomycoses; Humans; Immunocompetence; Male; Middle Aged; Mitosporic Fungi; Necrosis

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology